top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
49452-4140-01 | J2060 | INJECTION, LORAZEPAM, 2 MG | LORAZEPAM (U.S.P.) | NA |
49452-4140-02 | J2060 | INJECTION, LORAZEPAM, 2 MG | LORAZEPAM (U.S.P.) | NA |
49452-4140-03 | J2060 | INJECTION, LORAZEPAM, 2 MG | LORAZEPAM (U.S.P.) | NA |
49452-4140-04 | J2060 | INJECTION, LORAZEPAM, 2 MG | LORAZEPAM (U.S.P.) | NA |
49452-4300-01 | J3475 | INJECTION, MAGNESIUM SULFATE, PER 500 MG | MAGNESIUM SULFATE HEPTAHYDRATE (U.S.P.,E.P.,B.P.,J.P.) | NA |
49452-4300-02 | J3475 | INJECTION, MAGNESIUM SULFATE, PER 500 MG | MAGNESIUM SULFATE HEPTAHYDRATE (U.S.P.,E.P.,B.P.,J.P.) | NA |
49452-4300-03 | J3475 | INJECTION, MAGNESIUM SULFATE, PER 500 MG | MAGNESIUM SULFATE HEPTAHYDRATE (U.S.P.,E.P.,B.P.,J.P.) | NA |
49452-4380-01 | J2150 | INJECTION, MANNITOL, 25% IN 50 ML | MANNITOL (U.S.P.) | NA |
49452-7660-01 | J1071 | INJECTION, TESTOSTERONE CYPIONATE, 1MG | TESTOSTERONE CYPIONATE (U.S.P.) | NA |
49452-7660-02 | J1071 | INJECTION, TESTOSTERONE CYPIONATE, 1MG | TESTOSTERONE CYPIONATE (U.S.P.) | NA |
49452-7660-03 | J1071 | INJECTION, TESTOSTERONE CYPIONATE, 1MG | TESTOSTERONE CYPIONATE (U.S.P.) | NA |
49452-7720-01 | J2810 | INJECTION, THEOPHYLLINE, PER 40 MG | THEOPHYLLINE ANHYDROUS (U.S.P.) | NA |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
